<DOC>
	<DOCNO>NCT00808977</DOCNO>
	<brief_summary>The purpose study obtain first clinical assessment safety dersalazine sodium ulcerative colitis patient mild moderate disease .</brief_summary>
	<brief_title>A Phase II Study Explore Safety Activity Dersalazine Patients With Mild Moderate Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Age 18 65 inclusive Male , nonchildbearing female fertile female appropriate contraception . Mild moderate confirm active ulcerative colitis Able willing give inform consent Colitis cause Pregnancy , inadequate contraception fertile female patient Liver kidney disease , unstable cardiovascular disease , coagulation disorder . Other significant medical condition preclude participation investigator criterion Allergy hypersensitivity salicylates Previous concomitant treatment ulcerative colitis interfere safety activity assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>